المؤلفون: Van Riel, CAM, Van Den Reek, JMPA, Soenen, R., Schots, L., Van dER Schoots, LS., Willaert, F., Hillary, T., Van Lümig, PPM., Ghislain, PD., Ossenkoppele, PM., Lanssens, S., Prens, B., Temmerman, L., Van Doorn, MBA., Van Der Voort, EAM., De Bruin-Weller, MS., Horvath, B., Nikkels, Arjen, Dierckxens, L., Berends, MAM., Dodemont, SRP., Bovenschen, HJ., Lambert, JLW., De Jong, EMGJ.

المصدر: EADV, Berlin, Germany [DE], du 10 octobre 2023 au 13 octobre 2023

مصطلحات موضوعية: Human health sciences, Dermatology, Sciences de la santé humaine, Dermatologie

وصف الملف: 1

URL الوصول: https://orbi.uliege.be/handle/2268/310105

المؤلفون: Thomas SE; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands. sarah.thomas@radboudumc.nl., Seyger MMB; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands., Mangnus JE; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands., Gostynski AH; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands., Njoo MD; Department of Dermatology, Ziekenhuisgroep Twente, Almelo, Hengelo, The Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuisgroep Twente, Almelo, Hengelo, The Netherlands., Haeck IM; Department of Dermatology, Utrecht Medisch Centrum, Utrecht, The Netherlands., Hendricksen-Roelofzen JHJ; Department of Dermatology, Streekziekenhuis Koningin Beatrix, Winterswijk, The Netherlands., Körver JEM; Department of Dermatology, Amphia Ziekenhuis, Breda, The Netherlands., Dodemont SRP; Department of Dermatology, Catharina Ziekenhuis, Eindhoven, The Netherlands., Tupker RA; Department of Dermatology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands., Berends MAM; Department of Dermatology, Slingeland Ziekenhuis, Doetinchem, The Netherlands., Weppner-Parren LMJT; Department of Dermatology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, The Netherlands., Keijsers RRMC; Department of Dermatology, Zuyderland Medisch Centrum, Sittard-Geleen, Heerlen, The Netherlands., Oostveen AM; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Peters B; Department of Dermatology, Ziekenhuis Rijnstate, Arnhem, The Netherlands., Mommers R; Department of Dermatology, Anna Ziekenhuis, Geldrop, The Netherlands., van Doorn MBA; Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands., Tjioe M; Department of Dermatology, Bravis, Bergen op Zoom, The Netherlands/dermaTeam, Middelburg, The Netherlands., Veldkamp WR; Department of Dermatology, Ziekenhuis Gelderse Vallei, Ede, The Netherlands., Kuijpers ALA; Department of Dermatology, Máxima MC, Eindhoven, The Netherlands., Kleinpenning MM; Department of Dermatology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud University, Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, 6500 HB, Nijmegen, The Netherlands.

المصدر: American journal of clinical dermatology [Am J Clin Dermatol] 2024 Jul; Vol. 25 (4), pp. 685-688. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Letter

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Psoriasis*/drug therapy , Psoriasis*/immunology , Ustekinumab*/therapeutic use , Interleukin-23*/antagonists & inhibitors , Interleukin-23*/immunology , Dermatologic Agents*/therapeutic use , Drug Substitution*, Humans ; Treatment Outcome ; Female ; Male ; Middle Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Adult ; Severity of Illness Index ; Retrospective Studies ; Adalimumab/therapeutic use

المؤلفون: van Hal TW; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Wenink MH; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Ossenkoppele PM; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Njoo MD; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Oostveen A; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Peters B; Department of Dermatology, Ziekenhuis Rijnstate, Arnhem, the Netherlands., Tjioe M; Department of Dermatology/DermaTeam, Bravis Ziekenhuis, Bergen op Zoom, the Netherlands., Kop EN; Department of Dermatology, Bernhoven Ziekenhuis, Uden, the Netherlands., Körver JEM; Department of Dermatology, Amphia Ziekenhuis, Breda, the Netherlands., Dodemont SRP; Department of Dermatology, Catharina Ziekenhuis, Eindhoven, the Netherlands., Kleinpenning MM; Department of Dermatology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands., Berends MAM; Department of Dermatology, Slingeland Ziekenhuis, Doetinchem, the Netherlands., Veldkamp WR; Department of Dermatology, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., van Doorn MBA; Department of Dermatology, ErasmusMC, Rotterdam, the Netherlands., Mommers JM; Department of Dermatology, St. Anna Ziekenhuis, Geldrop, the Netherlands., Lindhout RJ; Department of Dermatology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands., Kuijpers ALA; Department of Dermatology, Maxima Medisch Centrum, Eindhoven, the Netherlands., van Lümig PP; Department of Dermatology, Maastricht UMC+, Maastricht, the Netherlands., de Jonge CEJ; Department of Dermatology, UMC Utrecht, Utrecht, the Netherlands., Tupker RA; Department of Dermatology, Sint Antoniusziekenhuis, Nieuwegein, the Netherlands., Hendricksen J; Department of Dermatology, Streekziekenhuis Koningin Beatrix, Winterswijk, the Netherlands., Keijsers RR; Department of Dermatology, Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands., van den Hoogen FHJ; Faculty of Medical Sciences, Radboud University, Nijmegen, the Netherlands., Vriezekolk JE; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Department of Research & Innovation, Sint Maartenskliniek, Nijmegen, the Netherlands., de Jong EMGJ; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands.

المصدر: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2304025. Date of Electronic Publication: 2024 Jan 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE

مواضيع طبية MeSH: Activities of Daily Living* , Psoriasis*, Humans ; Prospective Studies ; Cognition ; Registries

المؤلفون: Ter Haar ELM; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Elke.terHaar@radboudumc.nl.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands. Elke.terHaar@radboudumc.nl., Thomas SE; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., Njoo MD; Department of Dermatology, Ziekenhuisgroep Twente, Almelo/Hengelo, The Netherlands., Ossenkoppele PM; Department of Dermatology, Ziekenhuisgroep Twente, Almelo/Hengelo, The Netherlands., Kop EN; Department of Dermatology, Bernhoven Ziekenhuis, Uden, The Netherlands., Dodemont SRP; Department of Dermatology, Catharina Ziekenhuis, Eindhoven, The Netherlands., Körver JEM; Department of Dermatology, Amphia Ziekenhuis, Breda, The Netherlands., Kuijpers ALA; Department of Dermatology, Máxima Medisch Centrum, Eindhoven, The Netherlands., Lindhout RJ; Department of Dermatology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, The Netherlands., Tupker RA; Department of Dermatology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands., Mommers JM; Department of Dermatology, Anna Ziekenhuis, Geldrop, The Netherlands., Berends MAM; Department of Dermatology, Slingeland Ziekenhuis, Doetinchem, The Netherlands., Koetsier MIA; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., de Bruin-Weller MS; Department of Dermatology, Utrecht Medisch Centrum, Utrecht, The Netherlands., Visch MB; Department of Dermatology, Ziekenhuis Rijnstate, Arnhem, The Netherlands., Arnold WP; Department of Dermatology, Ziekenhuis Gelderse Vallei, Ede, The Netherlands., van Lümig PPM; Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands., Kleinpenning MM; Department of Dermatology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Lubeek SFK; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands., de Jong EMGJ; Department of Dermatology, Radboud University Medical Centre (Radboudumc), PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.; Radboud University, Nijmegen, The Netherlands.

المصدر: Drugs & aging [Drugs Aging] 2022 Sep; Vol. 39 (9), pp. 715-727. Date of Electronic Publication: 2022 Jul 21.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products*/therapeutic use , Psoriasis*/drug therapy, Aged ; Humans ; Prospective Studies ; Registries ; Treatment Outcome

المؤلفون: Adan F; Department of Dermatology, Maastricht University Medical Centre+, Maastricht, Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands. Electronic address: fieke.adan@mumc.nl., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, Netherlands., Essers BAB; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, Netherlands., Brinkhuizen T; Department of Dermatology, Maastricht University Medical Centre+, Maastricht, Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands; Department of Dermatology, Catharina Hospital, Eindhoven, Netherlands., Dodemont SRP; Department of Dermatology, Catharina Hospital, Eindhoven, Netherlands., Kessels JPHM; Department of Dermatology, Zuyderland Medical Centre, Heerlen, Netherlands., Quaedvlieg PJF; Department of Dermatology, Zuyderland Medical Centre, Heerlen, Netherlands., Dermont GJ; Department of Dermatology, Maastricht University Medical Centre+, Maastricht, Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands., Winnepenninckx VJL; Department of Pathology, Maastricht University Medical Centre+, Maastricht, Netherlands., Abdul Hamid M; Department of Pathology, Maastricht University Medical Centre+, Maastricht, Netherlands., Kelleners-Smeets NWJ; Department of Dermatology, Maastricht University Medical Centre+, Maastricht, Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands., Mosterd K; Department of Dermatology, Maastricht University Medical Centre+, Maastricht, Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands.

المصدر: The Lancet. Oncology [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. 1087-1096. Date of Electronic Publication: 2022 Jul 11.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Basal Cell*/diagnostic imaging , Carcinoma, Basal Cell*/therapy , Skin Neoplasms*, Adolescent ; Adult ; Biopsy ; Humans ; Netherlands ; Tomography, Optical Coherence ; Treatment Outcome

المؤلفون: Van Muijen ME; Department of Dermatology, Radboud University Medical Centre (Radboudumc), Mailbox 9101, NL-6500 HB Nijmegen, The Netherlands. marloes.vanmuijen@radboudumc.nl., Thomas SE, Groenewoud HMM, Otero ME, Ossenkoppele PM, Njoo MD, Dodemont SRP, Kop EN, Berends MAM, Koetsier MIA, Mommers JM, Körver JEM, Tupker RA, De Bruin-Weller MS, Weppner-Parren LJMT, Peters B, Kleinpenning MM, Kuijpers ALA, Arnold WP, Van Lümig PPM, Van den Reek JMPA, De Jong EMGJ

المصدر: Acta dermato-venereologica [Acta Derm Venereol] 2022 May 16; Vol. 102, pp. adv00712. Date of Electronic Publication: 2022 May 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-2057 (Electronic) Linking ISSN: 00015555 NLM ISO Abbreviation: Acta Derm Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products*/adverse effects , Psoriasis*/diagnosis , Psoriasis*/drug therapy, Adalimumab/therapeutic use ; Cohort Studies ; Etanercept/therapeutic use ; Humans ; Immunologic Factors ; Prospective Studies ; Severity of Illness Index ; Treatment Outcome ; Ustekinumab/therapeutic use